查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608068

植入式心臟整流去顫器市場：按植入部位、產品和最終用戶分類 - 2025-2030 年全球預測

Implantable Cardioverter Defibrillators Market by Implantation Location, Product, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年植入式心臟整流去顫器市值為45億美元，預計到2024年將達到47.3億美元，複合年成長率為5.91%，預計到2030年將達到67.3億美元。

植入式心臟整流去顫器(ICD) 是一種旨在檢測和治療危及生命的心律不整的設備，為心臟麻痹高風險患者提供重要的干涉措施。由於老化、生活方式改變和遺傳傾向等因素，全世界心血管疾病的盛行率不斷增加，因此需要 ICD。 ICD 是緊急干預領域的先驅，它可以持續監測心律，並在必要時進行電擊以使其恢復正常。該市場的主要最終用戶包括醫院、診所和門診手術中心，在這些地方，快速獲得這些挽救生命的治療至關重要。這個市場受到人們對心血管健康意識的提高以及使 ICD 更加高效和患者友好的技術進步的顯著影響。整合人工智慧以提高設備效率、小型化以提高患者舒適度以及延長電池壽命代表著潛在的成長機會。然而，市場面臨挑戰，ICD 價格高昂和嚴格的監管合規阻礙了新創新的快速推出。此外，對設備併發症的懷疑可能會影響患者的接受度。為了應對這些挑戰，建議專注於具有成本效益的製造方法並確保嚴格的安全標準。潛在的創新領域包括研究用於設備組件的生物分解性材料以及增強預測演算法以提高心律不整檢測的準確性。 ICD 市場競爭激烈且發展迅速，需要持續的技術創新和監管合規性。強調與醫療保健提供者的合作、加深對現實世界的洞察以及客製化解決方案以滿足不同的世界和需求，可以讓您在這個動態的環境中獲得優勢。儘管存在這些障礙，ICD 市場仍具有巨大的成長和創新潛力，預計將大大有助於改善患者的治療效果，特別是在心臟治療方面。

主要市場統計
基準年[2023] 45億美元
預測年份 [2024] 47.3億美元
預測年份 [2030] 67.3億美元
複合年成長率（%） 5.91%

市場動態：快速發展的植入式心臟整流去顫器市場的關鍵市場洞察

供需的動態交互作用正在改變植入式心臟整流去顫器市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 隨著患有心血管疾病的人口老化，人們對 ICD 益處的認知不斷提高。
    • 有效治療心律不整、心室顫動、心室心搏過速所引起的心臟麻痹
    • 世界各地有關 ICD 的培訓和宣傳計劃數量增加
  • 市場限制因素
    • 技術問題導致大量產品召回
  • 市場機會
    • 新技術的出現以及 S-ICD 和 ICD 的採用增加
    • 新興國家對 ICD 的需求不斷成長
  • 市場挑戰
    • 某些國家對突發心臟病的認知較低

波特五力：駕馭植入式心臟整流去顫器市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解外部對植入式心臟整流去顫器市場的影響

外部宏觀環境因素在塑造植入式心臟整流去顫器市場的性能動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解植入式心臟整流去顫器市場的競爭格局

對植入式心臟整流去顫器市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位植入式心臟整流去顫器市場供應商的績效評估

FPNV定位矩陣是評估植入式心臟整流去顫器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪植入式心臟整流去顫器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，植入式心臟整流去顫器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 患有心血管疾病的老化人口不斷增加，人們對 ICD 裝置益處的認知不斷增強
      • 有效治療心律不整、心室顫動、心室心搏過速所引起的心臟麻痹。
      • ICD 培訓和意識計劃在全球範圍內增加
    • 抑制因素
      • 經常導致產品召回的相關技術問題
    • 機會
      • 新技術的出現以及 S-ICD 和 ICD 的採用增加
      • 新興國家對 ICD 的需求不斷增加
    • 任務
      • 有些國家對突發心臟病的認知有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章植入式心臟整流去顫器

  • 皮下植入式心臟整流去顫器
  • 植入式心臟整流去顫器

第7章植入式心臟整流去顫器市場：依產品

  • 雙心室/心臟再同步治療心臟去顫器
  • 雙腔室ICD
  • 單腔ICD

第8章植入式心臟整流去顫器市場：依最終用戶分類

  • 門診治療室
  • 心臟中心
  • 電生理實驗室
  • 居家照護環境
  • 醫院/診所

第9章美洲植入式心臟整流去顫器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太植入式心臟整流去顫器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲植入式心臟整流去顫器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AtaCor Medical, Inc.
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova plc
  • Medtronic plc
  • MicroPort Scientific Corporation
Product Code: MRR-037F3DB25943

The Implantable Cardioverter Defibrillators Market was valued at USD 4.50 billion in 2023, expected to reach USD 4.73 billion in 2024, and is projected to grow at a CAGR of 5.91%, to USD 6.73 billion by 2030.

Implantable Cardioverter Defibrillators (ICDs) are devices designed to detect and treat life-threatening arrhythmias, providing crucial interventions for patients with high risks of sudden cardiac arrest. Their necessity stems from the increasing prevalence of cardiovascular diseases globally due to factors such as aging populations, lifestyle changes, and genetic predisposition. ICDs are vanguards in emergency interventions, continuously monitoring heart rhythms and administering shocks to restore normalcy when needed. Key end-users in this market include hospitals, clinics, and ambulatory surgical centers, where quick access to such life-saving interventions is paramount. The market is significantly influenced by advancements in technology, which have made ICDs more efficient and patient-friendly, alongside a rising awareness of cardiovascular health. The integration of Artificial Intelligence in enhancing device efficacy, miniaturization for patient comfort, and battery life improvements represent potential opportunities for growth. However, the market faces challenges, including high costs of ICDs and strict regulatory compliances that can hinder the swift introduction of new innovations. Furthermore, skepticism about device complications can impact patient acceptance. To address these challenges, focusing on cost-effective production methods and ensuring rigorous safety standards are recommended. Potential areas for innovation include research into biodegradable materials for device components and enhancing the predictive algorithms for better arrhythmia detection accuracy. The nature of the ICD market is highly competitive and fast-evolving, necessitating continuous innovation and regulatory navigation. Emphasizing collaborations with healthcare providers for better real-world insights and tailoring solutions to meet diverse global needs could provide an edge in this dynamic landscape. Despite the hurdles, the ICD market presents substantial growth and innovation avenues, especially towards contributing significantly to enhancing patient outcomes in cardiac care.

KEY MARKET STATISTICS
Base Year [2023] USD 4.50 billion
Estimated Year [2024] USD 4.73 billion
Forecast Year [2030] USD 6.73 billion
CAGR (%) 5.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Cardioverter Defibrillators Market

The Implantable Cardioverter Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing aging population for cardiovascular diseases and rising awareness about advantages of ICD devices
    • Effective in treating sudden cardiac arrest caused due to cardiac arrhythmias, ventricular fibrillation and pulseless ventricular tachycardia
    • Increasing number of training and awareness programs across the globe for ICDs
  • Market Restraints
    • Associated technical issues with noticeable incidence of product recall
  • Market Opportunities
    • Emergence of new technologies and an increase in adoption of S-ICDs and ICDs
    • Growing demand of ICDs from emerging economies
  • Market Challenges
    • Limited awareness about sudden cardiac attack in the certain countries

Porter's Five Forces: A Strategic Tool for Navigating the Implantable Cardioverter Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Cardioverter Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Implantable Cardioverter Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Cardioverter Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Implantable Cardioverter Defibrillators Market

A detailed market share analysis in the Implantable Cardioverter Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Cardioverter Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Cardioverter Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Cardioverter Defibrillators Market

A strategic analysis of the Implantable Cardioverter Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Implantable Cardioverter Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AtaCor Medical, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova plc, Medtronic plc, and MicroPort Scientific Corporation.

Market Segmentation & Coverage

This research report categorizes the Implantable Cardioverter Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Implantation Location, market is studied across Subcutaneous Implantable Cardioverter Defibrillator and Transvenous Implantable Cardioverter Defibrillator.
  • Based on Product, market is studied across Biventricular/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICD, and Single-Chamber ICD.
  • Based on End User, market is studied across Ambulatory Care Unit, Cardiac Center, Electrophysiology Laboratory, Home Care Setting, and Hospital & Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population for cardiovascular diseases and rising awareness about advantages of ICD devices
      • 5.1.1.2. Effective in treating sudden cardiac arrest caused due to cardiac arrhythmias, ventricular fibrillation and pulseless ventricular tachycardia
      • 5.1.1.3. Increasing number of training and awareness programs across the globe for ICDs
    • 5.1.2. Restraints
      • 5.1.2.1. Associated technical issues with noticeable incidence of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new technologies and an increase in adoption of S-ICDs and ICDs
      • 5.1.3.2. Growing demand of ICDs from emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness about sudden cardiac attack in the certain countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Implantable Cardioverter Defibrillators Market, by Implantation Location

  • 6.1. Introduction
  • 6.2. Subcutaneous Implantable Cardioverter Defibrillator
  • 6.3. Transvenous Implantable Cardioverter Defibrillator

7. Implantable Cardioverter Defibrillators Market, by Product

  • 7.1. Introduction
  • 7.2. Biventricular/Cardiac Resynchronization Therapy Defibrillators
  • 7.3. Dual-Chamber ICD
  • 7.4. Single-Chamber ICD

8. Implantable Cardioverter Defibrillators Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Unit
  • 8.3. Cardiac Center
  • 8.4. Electrophysiology Laboratory
  • 8.5. Home Care Setting
  • 8.6. Hospital & Clinic

9. Americas Implantable Cardioverter Defibrillators Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Implantable Cardioverter Defibrillators Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Implantable Cardioverter Defibrillators Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AtaCor Medical, Inc.
  • 3. BIOTRONIK SE & Co KG
  • 4. Boston Scientific Corporation
  • 5. Koninklijke Philips N.V.
  • 6. LivaNova plc
  • 7. Medtronic plc
  • 8. MicroPort Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET RESEARCH PROCESS
  • FIGURE 2. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET DYNAMICS
  • TABLE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY CARE UNIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY ELECTROPHYSIOLOGY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY IMPLANTATION LOCATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023